Table 2 Clinical and biochemical characteristics of PD patients in this study (n = 93)

Age (year)

63.0±13.1

59.1±13.4

1.397

0.166

Diabetes (n, %)

15 (39.5)

23 (41.8)

0.180

0.671

Male (n, %)

20 (52.6)

31 (56.4)

0.126

0.722

Atherosclerosis (n, %)

23 (60.5)

20 (36.4)

3.699

0.054

Peritonitis (n, %)

8 (21.1)

9 (16.4)

0.331

0.565

Dialysis duration (months)

36.4±26.5

28.4±22.6

1.576

0.118

Number of Hospitalizations

11.56±7.7

7.8±4.7

2.701

0.009

BMI (kg/m²)

21.7±3.1

23.5±2.7

−2.899

0.006

Serum albumin (g/L)

31.1±4.5

33.9±4.4

−3.092

0.003

Prealbumin (g/L)

0.3±0.1

0.4±0.1

−2.706

0.009

Creatinine (μmol/L)

886.6±275.6

911.7±322.6

−0.392

0.696

GFR (mL/min/1.73m²)

5.0±1.5

5.1±2.2

−0.388

0.699

Hemoglobin (g/L)

98.8±17.2

107.4±21.6

−2.033

0.045

Ferritin (μg /L)

255.5±274.2

181.0±181.3

1.468

0.147

Transferrin (g/L)

1.72±0.49

1.83±0.46

−1.089

0.279

iPTH (pmol/L)

326.6±267. 6

291.3±209.0

0.712

0.478

Calcium (mmol/L)

2.2±0.3

2.2±0.2

−1.167

0.246

Phosphorus (mmol/L)

1.7±0.8

1.7±0.4

0.131

0.896

Sodium (mmol/L)

140.6±3.7

139.7±7.3

0.673

0.502

Potassium (mmol/L)

3.9±0.8

3.9±0.7

0.071

0.943

Cholesterol (mmol/L)

4.3±1.1

4.5±1.3

−0.547

0.586

Triglycerides (mmol/L)

1.7±0.9

2.3±1.4

−2.810

0.006

CRP (mg/L)

13.7±22.9

5.9±14.8

1.855

0.069

IL-6 (pg/mL)

13.5±16.1

7.1±3.9

2.166

0.038

TNF-α (ng/mL)

16.8±4.5

15.9±9.6

0.566

0.630

BNP (pg/mL)

768.0±1171.6

275.7±437.6

2.474

0.017

MIS

8.0±4.7

4.5±2.5

4.163

0.000

MIAS0 (n, %)

10 (26.3)

28 (50.9)

5.625

0.018

MIAS1 (n, %)

14 (36.8)

24 (43.6)

0.429

0.512

MIAS2 (n, %)

8 (21.1)

2 (3.6)

6.667

0.010

MIAS3 (n, %)

5 (13.2)

1 (1.8)

5.077

0.024

MIAS (1–3) (n, %)

28 (73.7)

27 (49.1)

5.979

0.014